SZScott D. Zawieja

Scott D. Zawieja

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Scott D. Zawieja has a total of 114 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Gαq/11-IP3R1-ANO1 pacemaking axis underlies pressure-induced lymphatic chronotropy

    by Michael J Davis, Hae Jin Kim, Min Li, Jorge A Castorena-Gonzalez, Mary E Schulz, Grace Pea, Soumiya Pal, Timothy Domeier, Joshua Scallan, Scott Earley, et al.

    The frequency of spontaneous lymphatic contractions is exquisitely sensitive to changes in intraluminal pressure, enabling lymph transport to be matched to the filling state of the lymphatic capillary network. The mechanistic basis of this mechanosensitive response was investigated using ex vivo contraction assays of mouse popliteal collecting vessels. Based on electrophysiological and transcriptional similarities between lymphatic muscle cells (LMCs) and arterial smooth muscle, we hypothesized that pressure-dependent chronotropy shares a parallel signaling process with pressure-induced arterial depolarization/constriction. Thus, we probed two potential mechanisms: (1) pressure-induced activation of mechanosensitive cation channels and (2) mechano-activation of GNAQ/GNA11-coupled G-protein receptors (GPCRs) that would generate second messengers to activate those channels. Contraction assays were combined with scRNA-seq analysis of the respective targets and use of transgenic mice. Our findings rule out significant roles for the mechanosensitive channels implicated in arterial myogenic constriction, as well as channels implicated in ionic pacemaking of other tissues. In contrast, smooth-muscle specific knock out or inhibition of ANO1, IP 3 R1, or GNAQ/GNA11 significantly abrogated pressure-induced chronotropy. These results support a scheme whereby mechano-activation of one or more GNAQ/GNA11-coupled GPCRs generates IP 3 , inducing sarcoplasmic reticulum Ca 2+ release through IP 3 R1, which drives depolarization through the activation of ANO1 Cl - channels. The major GPCRs expressed in LMCs were identified and ranked by scRNAseq analysis, but individual inhibition or knock out of the top 7 candidates failed to significantly impair pressure-induced chronotropy. Our results implicate one or more GNAQ/GNA11-coupled GPCRs in mediating this mechanosensitive process, but the specific GPCRs remain to be identified.

  • Guidelines for evaluating endothelial function in vascular tissue

    by Cameron G. McCarthy, Christian Aalkjær, Pooneh Bagher, Andreas M. Beyer, Ebbe Boedtkjer, Gisele F. Bomfim, Jerome W. Breslin, Ana M. Briones, Jorge A. Castorena-Gonzalez, Tiago J. Costa, et al.

    The endothelium plays a central role in maintaining vascular homeostasis by orchestrating vascular tone, inflammation, healing, permeability, and thrombosis. Assessing endothelial function in vascular tissue is essential for understanding the cellular and molecular mechanisms underlying cardiovascular physiology and pathology. Traditional approaches, such as wire and pressure myography, have been instrumental in defining endothelium-dependent responses and identifying key pharmacological targets. However, the complexity and heterogeneity of endothelial cells across vascular beds and their dynamic phenotypic changes in health and disease necessitate the incorporation of new investigative strategies. Emerging methodologies, including bulk and single-cell transcriptomics, proteomics, and advanced imaging, now provide unprecedented insights into endothelial cell diversity and function. A team of leading experts in the field, who collectively reached a consensus on the most widely used techniques to evaluate endothelial function, developed these guidelines. The document establishes best practices for assessing endothelial function, from endothelial cell cultures to isolated vascular tissues, integrating conventional functional assays with modern molecular approaches. By fostering methodological consistency and embracing innovation, our goal is to enhance rigor, reproducibility, understanding, and discovery in endothelial biology.


  • Open Access

    Lymphatic dysfunction is linked to disease pathogenesis in Duchenne muscular dystrophy animal models

    by Bhuvaneshwaran Subramanian, Shedreanna Johnson, Akshaya Narayanan, Wei Wang, Bonnie L. Seaberg, Jillian Ball, Ilse M. Paredes Mares, Ahana Majumder, Alexandria Aceves, Sarah E. Frazier, et al.

    Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disorder characterized by progressive muscle weakness and inflammation caused by mutations in the DMD gene. Chronic inflammation in DMD exacerbates the complications associated with disease progression. Since the lymphatic system plays a crucial role in regulating and resolving inflammation, our primary goal was to investigate whether lymphatics were dysregulated in skeletal muscle of DMD animals. We used the D2.mdx murine and golden retriever muscular dystrophy (GRMD) canine models, as well as mouse and rat lymphatic muscle cells (LMCs) to determine the role of dystrophin in lymphatic structure and function in skeletal muscles. Single-cell RNA sequencing data from control LMCs showed dystrophin expression, and protein results demonstrated that the 427-, 140-, and 71-kDa dystrophin isoforms were detectable in the LMCs from control mice, whereas the 427 kDa isoform was undetectable in LMCs derived from D2.mdx mice. Microlymphangiography and magnetic resonance lymphangiogram results showed a significant decrease in lymph transport in D2. mdx mice and GRMD dogs, respectively. Isolated flank lymphatic vessels from D2. mdx mice exhibited an increase in tonic contraction and a significant decrease in the phasic contractile frequency and amplitude, supporting lymphatic vessel dysfunction. The gene expression profile and immunofluorescence analyses of dystrophic muscle revealed inflammatory lymphangiogenesis in dystrophic muscle. Skeletal muscle tissues that showed improvement in function after adeno-associated virus-microdystrophin treatment also showed significant improvement in inflammatory lymphangiogenesis in GRMD dogs. Thus, these results show a linkage between lymphatic function and DMD pathogenesis that merits further investigation in DMD patients.

  • Open Access

    Cellular characterization of the mouse collecting lymphatic vessels reveals that lymphatic muscle cells are the innate pacemaker cells

    by Scott D Zawieja, Grace A Pea, Sarah E Broyhill, Advaya Patro, Karen H Bromert, Charles E Norton, Hae Jin Kim, Sathesh Kumar Sivasankaran, Min Li, Jorge A Castorena-Gonzalez, et al.

    Collecting lymphatic vessels (cLVs) exhibit spontaneous contractions with a pressure-dependent frequency, but the identity of the lymphatic pacemaker cell is still debated. Here, we combined immunofluorescence and scRNAseq analyses with electrophysiological methods to examine the cellular constituents of the mouse cLV wall and assess whether any cell type exhibited morphological and functional processes characteristic of pacemaker cells. We employed inducible Cre mouse models to target-specific cell populations including CkitCreER T2 to target interstitial cells of Cajal-like cells, PdgfrβCreER T2 to target pericyte-like cells; PdgfrαCreER TM to target CD34 + adventitial cells; and Myh11CreER T2 to target lymphatic muscle cells (LMCs) directly. These inducible Cre lines were crossed to the fluorescent reporter Rosa26 mTmG , the genetically encoded Ca 2+ sensor GCaMP6f, and the light-activated cation channel rhodopsin2 (ChR2). Only LMCs consistently, but heterogeneously, displayed spontaneous Ca 2+ events during the diastolic period of the contraction cycle, and whose frequency was modulated in a pressure-dependent manner. Further, optogenetic depolarization with ChR2 induced propagated contractions only in LMCs. Membrane potential recordings in LMCs demonstrated that the rate of diastolic depolarization significantly correlated with contraction frequency. These findings support the conclusion that LMCs, or a subset of LMCs, are responsible for mouse cLV pacemaking.


  • Open Access

    Regulation of Collecting Lymphatic Vessel Contractile Function by TRPV4 Channels

    by Mary E. Schulz, Victoria L. Akerstrom, Kejing Song, Sarah E. Broyhill, Min Li, Michelle D. Lambert, Tatia B. Goldberg, Raghu P. Kataru, Jinyeon Shin, Stephen E. Braun, et al.

    BACKGROUND: Dysregulation of TRPV4 (transient receptor potential vanilloid type 4)–mediated signaling has been associated with inflammation and tissue fibrosis, both of which are key features in the pathophysiology of lymphatic system diseases; however, the expression and functional roles of lymphatic TRPV4 channels remain largely unexplored. METHODS: We generated a single-cell RNA sequencing dataset from microdissected mouse collecting lymphatic vessels to characterize the expression of Trpv4 . Using a novel Trpv4 fx/fx mouse strain and the Cre-lines Prox1 -CreER T2 and LysM -Cre we assessed the role of TRPV4 channels in lymphatic endothelial cells and peri-lymphatic myeloid cells, respectively. Confocal microscopy and extensive functional experimentation on isolated and pressurized lymphatics, including measurements of intracellular calcium activity, were used to validate our single-cell RNA sequencing findings and to elucidate the underlying mechanisms. Clinical significance was assessed using biopsies from patients with breast cancer–related lymphedema. RESULTS: We characterized the single-cell transcriptome of collecting lymphatic vessels and surrounding tissues. Trpv4 was highly enriched in lymphatic endothelial cells and in a subset of Lyve1 + (lymphatic vessel endothelial hyaluronan receptor 1) macrophages displaying a tissue-resident profile. In clinical samples, breast cancer–related lymphedema was associated with increased infiltration of macrophages coexpressing LYVE1 and TRPV4. Pharmacological activation of TRPV4 channels led to contractile dysregulation in isolated collecting lymphatics. The response was multiphasic, including initial vasospasm and subsequent vasodilation and inhibition of contractions, which was associated with the activation of TXA2Rs (thromboxane A2 receptors) in lymphatic muscle cells by secreted prostanoids from TRPV4+ myeloid cells, and increased nitric oxide (and perhaps other vasodilatory prostanoids) from lymphatic endothelial cells. The TXA2R-mediated vasospasm resulted from increased mobilization of calcium from intracellular stores through inositol trisphosphate receptors and store-operated calcium entry. CONCLUSIONS: Our results uncovered a novel mechanism of lymphatic contractile dysregulation mediated by the crosstalk between TRPV4-expressing myeloid cells, including LYVE1+ macrophages, and lymphatic muscle cells or lymphatic endothelial cells. These findings highlight potentially important roles of TRPV4 channels in lymphatic dysfunction associated with inflammation, including secondary lymphedema.


  • Open Access

    Cellular characterization of the mouse collecting lymphatic vessels reveals that lymphatic muscle cells are the innate pacemaker cells

    by Scott D Zawieja, Grace A Pea, Sarah E Broyhill, Advaya Patro, Karen H Bromert, Charles E Norton, Hae J Kim, Sathesh K Sivasankaran, Min Li, Jorge A Castorena-Gonzalez, et al.

    Collecting lymphatic vessels (cLVs) exhibit spontaneous contractions with a pressure-dependent frequency, but the identity of the lymphatic pacemaker cell is still debated. Here we combined immunofluorescence and scRNAseq analyses with electrophysiological methods to examine the cellular constituents of the mouse cLV wall and assess whether any cell type exhibited morphological and functional processes characteristic of pacemaker cells. We employed inducible Cre (iCre) mouse models to target specific cell populations including c-kitCreERT2 to target interstitial cells of Cajal like cells; PdgfrβCreERT2 to target pericyte-like cells; PdgfrαCreERTMto target CD34+ adventitial cells; and Myh11CreERT2to target lymphatic muscle cells (LMCs) directly. These inducible Cre lines were crossed to the fluorescent reporter ROSA26mT/mG, the genetically encoded Ca2+ sensor GCaMP6f, and the light-activated cation channel rhodopsin2 (ChR2). Only LMCs consistently, but heterogeneously, displayed spontaneous Ca2+ events during the diastolic period of the contraction cycle, and whose frequency was modulated in a pressure-dependent manner. Further, optogenetic depolarization with ChR2 only induced propagated contractions in LMCs. Membrane potential recordings in LMCs demonstrated that the rate of diastolic depolarization significantly correlated with contraction frequency. These findings support the conclusion that LMCs, or a subset of LMCs, are responsible for mouse cLV pacemaking.


  • Open Access

    S1PR1 regulates lymphatic valve development and tertiary lymphoid organ formation in the ileum

    by Xin Geng, Lijuan Chen, Zoheb Ahmed, Guilherme Pedron Formigari, Yen-Chun Ho, Ilaria Del Gaudio, Marcella Neves Datilo, Zheila J. Azartash-Namin, Coraline Heron, Xindi Shan, et al.

    Efficient lymph flow is ensured by lymphatic valves (LVs). The mechanisms that regulate LV development are incompletely understood. Here, we show that the deletion of the GPCR sphingosine 1-phosphate receptor-1 (S1PR1) from lymphatic endothelial cells (LECs) results in fewer LVs. Interestingly, LVs that remained in the terminal ileum-draining lymphatic vessels were specifically dysfunctional. Furthermore, tertiary lymphoid organs (TLOs) formed in the terminal ileum of the mutant mice. TLOs in this location are associated with ileitis in humans and mice. However, mice lacking S1PR1 did not develop obvious characteristics of ileitis. Mechanistically, S1PR1 regulates shear stress signaling and the expression of the valve-regulatory molecules FOXC2 and connexin-37. Importantly, Foxc2+/− mice, a model for lymphedema-distichiasis syndrome, also develop TLOs in the terminal ileum. Thus, we have discovered S1PR1 as a previously unknown regulator of LV and TLO development. We also suggest that TLOs are a sign of subclinical inflammation that can form due to lymphatic disorders in the absence of ileitis.


  • Open Access

    Modelling pacemaker oscillations in lymphatic muscle cells: lengthened action potentials by two distinct system effects

    by Edward J. Hancock, Charlie Macaskill, Scott D. Zawieja, Michael J. Davis, Christopher D. Bertram

    Lymphatic system failures contribute to cardiovascular and various other diseases. A critical function of the lymphatic vascular system is the active pumping of fluid from the interstitium back into the blood circulation by periodic contractions of lymphatic muscle cells (LMCs) in the vessel walls. As in cardiac pacemaking, these periodic contractions can be interpreted as occurring due to linked pacemaker oscillations in the LMC membrane potential (M-clock) and calcium concentration (C-clock). We previously reported a minimal model of synchronized dual-clock-driven oscillations. While this qualitatively replicated the period of oscillations under different conditions, it did not replicate the action potential shape as it varied under those conditions, particularly as regards the extent or lack of a systolic plateau. Here, we modify the model to replicate the plateau behaviour. Using phase-plane analysis we show two qualitatively different dynamical mechanisms that could account for plateau formation, one largely M-clock-driven, the other largely C-clock-driven. The second case occurs with the introduction of a ryanodine receptor; in both cases, we find improved predictions for calcium levels. With enhanced fidelity to the experimental data, the improved model has the potential to help determine opportunities for pharmacological treatment of lymphatic system pumping defects.


  • Open Access

    Connexin-45 is expressed in mouse lymphatic endothelium and required for lymphatic valve function

    by Michael J. Davis, Jorge A. Castorena-Gonzalez, Min Li, Scott D. Zawieja, Alex M. Simon, Xin Geng, R. Sathish Srinivasan

    The expression and functional relevance of the gap junction molecule connexin-45 (Cx45; GJC1 ) in lymphatic endothelium were not previously known. We found that Cx45 was expressed widely in the endothelium of murine lymphatics, in both valve and nonvalve regions. Cell-specific deletion of Cx45, driven by a constitutive Cre line ( Lyve1-Cre ) or an inducible Cre line ( Prox1-CreER T2 ), compromised the function of lymphatic valves, as assessed by physiological tests (back leak and closure) of isolated, single-valve vessel segments. The defects were comparable to those previously reported for loss of Cx43, and as with Cx43, deletion of Cx45 resulted in shortening or increased asymmetry of lymphatic valve leaflets, providing an explanation for the compromised valve function. In contrast with Cx43, lymphatic endothelial cell–specific (LEC-specific) deletion of Cx45 did not alter the number of valves in mesenteric or dermal lymphatic networks or the expression patterns of the canonical valve-associated proteins PROX1, ITGA9, or CLAUDIN5. Constitutive deletion of Cx45 from LECs resulted in increased backflow of injected tracer in popliteal networks in vivo and compromised the integrity of the LEC permeability barrier in a subset of collecting vessels. These findings provide evidence for an unexpected role of Cx45 in the development and maintenance of lymphatic valves.


  • Loss of anoctamin 1 reveals a subtle role for BK channels in lymphatic muscle action potentials

    by Rebecca C. Harlow, Grace A. Pea, Sarah E. Broyhill, Advaya Patro, Karen H. Bromert, Randolph H. Stewart, Cristine L. Heaps, Jorge A. Castorena‐Gonzalez, Ranjeet M. Dongaonkar, Scott D. Zawieja

    Ca2+ signalling plays a crucial role in determining lymphatic muscle cell excitability and contractility through its interaction with the Ca2+‐activated Cl− channel anoctamin 1 (ANO1). In contrast, the large‐conductance (BK) Ca2+‐activated K+ channel (KCa) and other KCa channels have prominent vasodilatory actions by hyperpolarizing vascular smooth muscle cells. Here, we assessed the expression and contribution of the KCa family to mouse and rat lymphatic collecting vessel contractile function. The BK channel was the only KCa channel consistently expressed in fluorescence‐activated cell sorting‐purified mouse lymphatic muscle cell lymphatic muscle cells. We used a pharmacological inhibitor of BK channels, iberiotoxin, and small‐conductance Ca2+‐activated K+ channels, apamin, to inhibit KCa channels acutely in ex vivo isobaric myography experiments and intracellular membrane potential recordings. In basal conditions, BK channel inhibition had little to no effect on either mouse inguinal–axillary lymphatic vessel (MIALV) or rat mesenteric lymphatic vessel contractions or action potentials (APs). We also tested BK channel inhibition under loss of ANO1 either by genetic ablation (Myh11CreERT2‐Ano1 fl/fl, Ano1ismKO) or by pharmacological inhibition with Ani9. In both Ano1ismKO MIALVs and Ani9‐pretreated MIALVs, inhibition of BK channels increased contraction amplitude, increased peak AP and broadened the peak of the AP spike. In rat mesenteric lymphatic vessels, BK channel inhibition also abolished the characteristic post‐spike notch, which was exaggerated with ANO1 inhibition, and significantly increased the peak potential and broadened the AP spike. We conclude that BK channels are present and functional on mouse and rat lymphatic muscle cells but are otherwise masked by the dominance of ANO1. image Key points: Mouse and rat lymphatic muscle cells express functional BK channels. BK channels make little contribution to either rat or mouse lymphatic collecting vessel contractile function in basal conditions across a physiological pressure range. ANO1 limits the peak membrane potential achieved in the action potential and sets a plateau potential limiting the voltage‐dependent activation of BK. BK channels are activated when ANO1 is absent or blocked and slightly impair contractile strength by reducing the peak membrane potential achieved in the action potential spike and accelerating the post‐spike repolarization.